But we dont need to go under the knife, or take a $1,000-a-month drug to decrap our diet
We identified the gallbladder or biliary diseases on the basis of the classifications in the Medical Dictionary for Regulatory Activities (MedDRA) version 22.0
As these medications become among the most widely prescribed in the world, the ability to tailor treatment based on genetic profile or to target specific clinical outcomes such as cardiovascular risk reduction could transform prescribing practices well beyond their current primary use in obesity and diabetes management Sources New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects 23andME April 8, 2026 Genetic variations linked to weight loss, side effects from GLP-1 drugs Reuters April 10, 2026
van Gisbergen, M
While we currently treat these patients as a single group defined simply as obese, the future will likely demand more personalized approaches, said DiMarchi
We uncover topics around weight loss, side effects of different GLP-1 RAs, and concerns about drug access and supply, with a mainly neutral-to-positive view of GLP-1 RAs, highlighting the role of an AI-enabled pipeline to help monitor for emerging side effects, uncover public sentiment, and guide future directions for research and public health efforts
